The one-year doping ban on former Asian silver-medallist boxer Sumit Sangwan was on Monday lifted after he proved that his intake of a banned substance was unintentional in a hearing conducted by the National Anti-Doping Agency (NADA) here.
"Sumit has been cleared and his ban lifted as he has convinced the NADA panel that the diuretic he tested positive for was a case of unintentional intake," a Boxing Federation of India official told PTI.
Sangwan was banned for a year in December 2019 after testing positive for Acetazolamide, listed as a diuretic and masking agent under World Anti-Doping Agency's (WADA) 2019 Prohibited List.
"I am relieved, a huge weight is off my shoulders. I knew I wasn't in the wrong. I am glad I could prove myself," an emotional Sangwan said.
He had maintained that it was a case of unintentional intake as he had duly consulted a doctor before taking the medication for an eye infection.
The suspension, however, cost Sangwan dearly as the 2012 Olympian missed out on appearing for trials for this year's Tokyo Olympics.
Sangwan's sample was collected "out of competition" on October 10 last year.
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
